France· FR:60892664
GANFORT 0,3 mg/ml + 5 mg/ml, collyre en solution en récipient unidose
A medicinal product containing maléate de timolol + bimatoprost, registered in France by ABBVIE DEUTSCHLAND (ALLEMAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MALÉATE DE TIMOLOL + BIMATOPROST
- Manufacturer
- ABBVIE DEUTSCHLAND (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340092756162730 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 0,4 mlEUR 8.43
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Maléate de timolol + bimatoprost in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBimatoprost 300micrograms/ml / Timolol 5mg/ml eye dropsBlumont Pharma Ltd
- NetherlandsBimatoprost/Timolol axunio 0,3 mg/ml + 5 mg/ml oogdruppels, oplossingaxunio Pharma GmbH
- SpainBAPIRI 0,3 MG + 5 MG/ML COLIRIO EN SOLUCIONBrill Pharma S.L.
- GermanyBapiriTrb Chemedica Ag
- ItalyBIMATOPROST E TIMOLOLO TEVATEVA ITALIA S.R.L.
- CzechiaBIMATOPROST/TIMOLOL OLIKLAOlikla s.r.o., Kostelec nad Černými Lesy
- FinlandBimatoprost/Timolol MylanMylan AB
- SwitzerlandBimatoprost-Mepha Plus
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Bimatoprost/Timolol Genetic, Bimatoprost/Timolol Stada Arzneimittel Ag
- Belgium · Duelym, Ganzed
- Bulgaria · Бимасопт, Биматопрост Дуо
- Cyprus · Birmost-Co, Duelym
- Czechia · Bimatoprost/Timolol Olikla, Duelym
- Germany · Bapiri, Bimatoprost / Timolol Biogaran
- Denmark · Bimatoprost/Timolol Pharmathen, Bimatoprost/Timolol Stada
- Estonia · Bimatoprost/Timolol Elvim, Bimatoprost/Timolol Teva
- Spain · Bapiri, Bimatoprost/Timolol Stada
- Finland · Bimatoprost/Timolol Stada, Bitifrin
- United Kingdom (Northern Ireland) · Bimatoprost + Timolol Blumont Pharma, Bimatoprost/Timolol Aspire
- Greece · Birmost-Co, Duelym
- Croatia · Duelym
- Ireland · Bitifrin, Duelym
- Iceland · Bimatoprost/Timolol Stada, Duelym
- Italy · Bimatoprost E Timololo Eg, Bimatoprost E Timololo Mylan
- Liechtenstein · Ganfort
- Lithuania · Bimatoprost/Timolol Elvim, Bimatoprost/Timolol Teva
- Luxembourg · Duelym, Ganzed
- Latvia · Bapiri, Bimatoprost/Timolol Elvim
- Netherlands · Bimatoprost/Timolol Axunio, Bimatoprost/Timolol Blumont
- Norway · Bimabloc, Bimtim
- Poland · Bimaroz Duo, Bimifree Combi
- Portugal · Eduelym, Ibrigan
- Romania · Bimatoprost/Timolol Rompharm, Duelym
- Sweden · Bimabloc, Bimatoprost/Timolol Brown & Burk
- Slovakia · Bimatoprost/Timolol Olikla, Duelym
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/67f3f473-5f9c-4d85-88aa-3a3e6abc0918 GET /v1/drugs/67f3f473-5f9c-4d85-88aa-3a3e6abc0918?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60892664",
"date_amm": "2013-10-04",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/06/340",
"substance": "MALÉATE DE TIMOLOL + BIMATOPROST",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about maléate de timolol + bimatoprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.